ArticleJournal of pharmaceutical policy and practice2015

Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.

Agnes Vitry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.